Summary
This Form 8-K filing by WellPoint, Inc. (now Elevance Health, Inc.) on March 21, 2005, primarily details executive compensation decisions for 2005 and highlights the company's confirmation of previously issued earnings guidance. The Compensation Committee of the Board of Directors authorized significant long-term incentive awards for 2004 performance for Named Executive Officers, with CEO Larry C. Glasscock receiving the largest payout of $2,023,620. Additionally, the filing outlines the 2005 salary, stock option grants, restricted stock awards, and annual bonus targets for several key executives, signaling a focus on performance-based incentives tied to metrics like earnings per share and membership growth.
Key Highlights
- 1WellPoint's Compensation Committee authorized 2004 long-term incentive awards for Named Executive Officers, totaling over $4 million in cash payments.
- 2CEO Larry C. Glasscock received the largest 2004 long-term incentive award at $2,023,620.
- 3The company established 2005 compensation packages for key executives, including salaries, stock options, and restricted stock awards, with vesting periods outlined.
- 42005 annual bonus targets are tied to performance metrics such as diluted EPS, synergy goals, and membership growth, with potential payouts ranging from 50% to 300% of target.
- 5The filing confirms that WellPoint expects to meet its previously issued earnings expectations for the period.
- 6Two executives, David R. Frick and Michael L. Smith, retired in late 2004/early 2005, impacting the composition of Named Executive Officers for 2005.